Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

79.78 +0.86 (+1.09%)
Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,735,971
Open 78.60
Bid (Size) 79.33 (100)
Ask (Size) 80.00 (200)
Prev. Close 78.92
Today's Range 78.00 - 79.93
52wk Range 65.94 - 87.89
Shares Outstanding 580,300,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire... 
Via MarketMinute

Performance

YTD
-6.5%
-6.5%
1 Month
-6.3%
-6.3%
3 Month
-6.3%
-6.3%
6 Month
-2.5%
-2.5%
1 Year
+6.8%
+6.8%

More News

Read More
News headline image
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Corp (NYSE:EW) Reports Mixed Q4 Results, Misses EPS Estimates ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
The Return of the Mega-Deal: How 2026’s Regulatory Pragmatism is Reshaping Corporate America
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗
Via MarketBeat
News headline image
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
Edwards Lifesciences (EW) Earnings Transcript ↗
Via The Motley Fool
News headline image
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
Via MarketMinute
Topics Supply Chain
News headline image
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants
Via MarketMinute
News headline image
Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors ↗
Via MarketBeat
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Death of the Quick Deal: One Year Under the New FTC and DOJ Merger Regime
Via MarketMinute
Topics Economy
News headline image
The Thrombectomy Titan: Boston Scientific Shakes MedTech with $14.5 Billion Penumbra Acquisition
Via MarketMinute
Topics Artificial Intelligence
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
From Equity Insider
Via GlobeNewswire
News headline image
Edwards Comments on JenaValve Acquisition
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The 2025 Dollar Rollercoaster: A Year-End Rally Masks a Historic Annual Retreat
Via MarketMinute
Topics Economy World Trade
News headline image
Edwards Lifesciences Corp (NYSE:EW) Shows Strong Technical Setup for Potential Breakout ↗
Via Chartmill

Frequently Asked Questions

Is Edwards Lifesciences publicly traded?
Yes, Edwards Lifesciences is publicly traded.
What exchange does Edwards Lifesciences trade on?
Edwards Lifesciences trades on the New York Stock Exchange
What is the ticker symbol for Edwards Lifesciences?
The ticker symbol for Edwards Lifesciences is EW on the New York Stock Exchange
What is the current price of Edwards Lifesciences?
The current price of Edwards Lifesciences is 79.78
When was Edwards Lifesciences last traded?
The last trade of Edwards Lifesciences was at 02/20/26 07:00 PM ET
What is the market capitalization of Edwards Lifesciences?
The market capitalization of Edwards Lifesciences is 46.30B
How many shares of Edwards Lifesciences are outstanding?
Edwards Lifesciences has 46B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.